stratifying patients with breast cancer by a 7-gene assay for endocrine therapy
Published 2 years ago • 208 plays • Length 6:23Download video MP4
Download video MP3
Similar videos
-
1:30
exploring endocrine therapy innovations for high-risk hormone receptor-positive breast cancer
-
1:19
gene expression assays to identify patients with breast cancer for neoadjuvant treatment
-
1:00
therapeutic strategies to maximize sensitivity to endocrine therapy in breast cancer
-
0:40
assessing the role of 21-gene assays in breast cancer
-
1:50
challenges with patient selection for extended adjuvant endocrine therapy in breast cancer
-
0:55
cambria-1: camizestrant vs standard endocrine therapy in breast cancer
-
1:08
the role of immunotherapy in endocrine-refractory luminal breast cancer
-
5:34
tailorx: phase 3 trial validating a 21-gene expression assay in breast cancer
-
1:40
dr. simon on genomic assays for patients with breast cancer
-
2:51
risk stratification of patients with hormone-receptor positive breast cancer
-
20:13
endocrine treatment in breast cancer
-
3:45
endocrine therapy benefits for stage 1 breast cancer
-
2:06
association of 80 gene signature reclassification with neoadjuvant treatment response in bc
-
1:36
nccn guidelines on molecular assays for patients with breast cancer
-
10:02
breast cancer: extended adjuvant endocrine therapy
-
53:02
breast cancer genes, risk assessment and screening - lawrence brody
-
1:06:08
breast cancer genetics, risk, and screening
-
4:11
targeted sequencing in endocrine refractory breast cancer
-
13:39
hormonal therapy for breast cancer: we teach you